My watch list

Lithium succinate


Lithium succinate
Systematic (IUPAC) name
lithium butanedioic acid
Identifiers
CAS number	?
ATC code	D11AX04
PubChem	65248
Chemical data
Formula	C₄H₅LiO₄
Mol. mass	124.02 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis^[1] and proposed for the treatment of anogenital warts.^[2]

Additional recommended knowledge

Essential Laboratory Skills Guide

Guide to balance cleaning: 8 simple steps

Don't let static charges disrupt your weighing accuracy

References

^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149-50. PMID 8358107.
^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515-7. PMID 9259500.

v • d • e Other dermatological preparations (D11)
Medicated shampoos	Cetrimide - Cadmium compounds - Selenium compounds - Povidone-iodine - Sulfur compounds - Xenysalate
Other dermatologicals	seborrhoeic dermatitis/dandruff (Lithium succinate, Pyrithione zinc) - skin whitening/depigmenting (Hydroquinone, Mequinol, Monobenzone) - anti-inflammatory/Immunomodulators (Oxaceprol, Gamolenic acid), Pimecrolimus, Tacrolimus) - baldness treatments (Finasteride, Minoxidil) - hair growth inhibiting agent (Eflornithine) - other (Calcium gluconate, Magnesium sulfate, Tiratricol)